Neuburgh Advisers’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $843K | Sell |
8,602
-578
| -6% | -$56.6K | 0.03% | 353 |
|
|
2019
Q2 | $1.2M | Sell |
9,180
-3,128
| -25% | -$410K | 0.04% | 300 |
|
|
2019
Q1 | $1.66M | Buy |
12,308
+3,026
| +33% | +$409K | 0.06% | 224 |
|
|
2018
Q4 | $904K | Sell |
9,282
-170
| -2% | -$16.6K | 0.04% | 285 |
|
|
2018
Q3 | $1.31M | Buy |
9,452
+102
| +1% | +$14.2K | 0.04% | 248 |
|
|
2018
Q2 | $1.16M | Buy |
9,350
+1,258
| +16% | +$156K | 0.04% | 273 |
|
|
2018
Q1 | $902K | Sell |
8,092
-340
| -4% | -$37.9K | 0.03% | 285 |
|
|
2017
Q4 | $1.01M | Buy |
8,432
+2,346
| +39% | +$281K | 0.04% | 281 |
|
|
2017
Q3 | $854K | Sell |
6,086
-1,088
| -15% | -$153K | 0.03% | 302 |
|
|
2017
Q2 | $873K | Buy |
7,174
+578
| +9% | +$70.3K | 0.03% | 293 |
|
|
2017
Q1 | $800K | Buy |
6,596
+1,020
| +18% | +$124K | 0.03% | 298 |
|
|
2016
Q4 | $682K | Buy |
+5,576
| New | +$682K | 0.03% | 296 |
|